BC
PFE icon

Barrett & Company’s Pfizer PFE Stock Holding History

Barrett & Company’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Sell
12,966
-64
-0.5% -$1.67K 0.09% 123
2026
Q1 		$366K Buy
13,030
+1
+0% +$27 0.13% 100
2025
Q4 		$324K Sell
13,029
-1,448
-10% -$36.5K 0.11% 104
2025
Q3 		$369K Buy
14,477
+13
+0.1% +$321 0.13% 99
2025
Q2 		$351K Sell
14,464
-87
-0.6% -$2.03K 0.13% 104
2025
Q1 		$369K Buy
14,551
+104
+0.7% +$2.72K 0.16% 96
2024
Q4 		$383K Buy
14,447
+13
+0.1% +$353 0.16% 87
2024
Q3 		$418K Sell
14,434
-54
-0.4% -$1.57K 0.18% 85
2024
Q2 		$405K Sell
14,488
-882
-6% -$24.3K 0.18% 82
2024
Q1 		$427K Sell
15,370
-88
-0.6% -$2.44K 0.2% 83
2023
Q4 		$445K Sell
15,458
-878
-5% -$26.5K 0.24% 82
2023
Q3 		$542K Buy
16,336
+149
+0.9% +$5.27K 0.32% 62
2023
Q2 		$594K Buy
16,187
+10
+0.1% +$389 0.34% 59
2023
Q1 		$660K Buy
16,177
+581
+4% +$25.1K 0.42% 53
2022
Q4 		$799K Hold
15,596
– – 0.53% 44
2022
Q3 		$799K Buy
+15,596
New +$758K 0.53% 44

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Barrett & Company's PFE Position: Q2 2026 in Review

Barrett & Company reduced its Pfizer (PFE) stake by 0.49% in Q2 2026, selling an estimated $1.67K and leaving 12,966 shares worth $312K. The position accounts for 0.09% of the portfolio, ranked #123.

Barrett & Company first reported a position in PFE in Q3 2022 and has held it in 16 quarters since. The position peaked at $799K in Q4 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Barrett & Company held 12,966 shares of Pfizer worth $312K as of Q2 2026.
  • Barrett & Company sold 64 Pfizer shares in Q2 2026, an estimated $1.67K.
  • Pfizer made up 0.09% of Barrett & Company's portfolio in Q2 2026, its #123 holding.
  • Barrett & Company first reported a position in Pfizer in Q3 2022 and has held it in 16 quarters since.
  • Barrett & Company's Pfizer position peaked at $799K in Q4 2022.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.